SLC2A1 and cancer: Therapeutic inhibitors targeting ER stress response sensitize tumor cells to GLUT inhibitors‐induced disulfidptosis and dramatically suppress tumor growth, conceptualizing combined therapy by targeting disulfidptosis in cancer treatments.